Drug class
Optical fluorescence imaging agent; protease-activated peptide-dye conjugate
Mechanism of action
After intravenous administration, proteolytic cleavage in the tumour microenvironment activates the pegulicianine fluorophore. The activated fluorophore emits near-infrared fluorescence when illuminated, enabling intraoperative visualisation of residual cancerous tissue in the lumpectomy cavity.
General use cases
- Adjunct fluorescence imaging in adults with breast cancer to assist intraoperative detection of cancerous tissue within the resection cavity after removal of the primary specimen during lumpectomy surgery; used with an approved fluorescence imaging system.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
